Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies.
about
Strategies to minimize antibiotic resistanceCan we prevent antimicrobial resistance by using antimicrobials better?Evolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapyMutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosisRole of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacinDoes High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic EfficacyPlasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries.Maintaining fluoroquinolone class efficacy: review of influencing factors.Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamicsNevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine primary resistance mutations in a clinical setting.Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae.Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance.Ciprofloxacin dosage and emergence of resistance in human commensal bacteriaMutant prevention concentration-based pharmacokinetic/pharmacodynamic indices as dosing targets for suppressing the enrichment of levofloxacin-resistant subpopulations of Staphylococcus aureusPrevention strategies for antimicrobial resistance: a systematic review of the literature.Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulationIntegration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle.Is selection relevant in the evolutionary emergence of drug resistance?The changing face of antibiotic prescribing: the mutant selection window.In vivo antimicrobial activity of marbofloxacin against Pasteurella multocida in a tissue cage model in calves.Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humansPharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.Mechanisms of resistance to quinolones.In vitro susceptibility of four antimicrobials against Riemerella anatipestifer isolates: a comparison of minimum inhibitory concentrations and mutant prevention concentrations for ceftiofur, cefquinome, florfenicol, and tilmicosin.In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis.Pharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection.Pharmacokinetic and Pharmacodynamic Integration and Modeling of Enrofloxacin in Swine for Escherichia coli.Levofloxacin for the treatment of community-acquired pneumonia.Mutant selection window hypothesis updated.Suppression of gyrase-mediated resistance by C7 aryl fluoroquinolones.Optimizing drug exposure to minimize selection of antibiotic resistance.Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model.Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae.A unified anti-mutant dosing strategy.Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolones.Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection modelCD101: a novel long-acting echinocandin.Quinolones: action and resistance updated.
P2860
Q24607946-E2D6C77A-82F2-406D-B332-DBF3D3C799E5Q26829707-C5A2B8D1-529C-4A63-9246-EF3912D2AAA7Q27016579-38DB521A-7B96-4DA4-8448-BF43F44A100EQ28344614-DC865AC2-CAD2-4DD2-AA96-A62BBEE6FEDCQ28492686-71EF95FE-BE85-4EF5-8488-41045AFE4A58Q28552950-06B24CE2-10A9-4E32-8888-F22C1C956519Q28554197-691CD11E-FD42-4C15-B33D-96E522569AA9Q30240591-10C48DD1-9EEE-4F76-B481-2C6272DEE35DQ30310427-0B3B2556-6D03-47B1-AAD1-DF75B7F16C3CQ33876556-1B741AC8-8A9A-406F-A991-93A88CEA604EQ33935458-BAE29CA2-97E2-4A46-B4B6-2F03D981BDB6Q33981343-4610A019-6BCC-44A4-BF32-2DD3B91E36ECQ34077142-DEBCAF46-D001-4120-BD2F-0A96923EED82Q34104262-4BFCF0CD-461C-4948-A366-CCAFC3B2E6DDQ34932274-90926E6D-16C1-4A2F-AEA1-FBEC102ED175Q35026563-416B990C-B62B-4476-8E44-9D545B501D4AQ35644095-BD2E564E-7D6D-4093-9BDE-72EDD67FDF82Q35750265-2F6FFF15-3F59-4E33-8336-791BFFF87D7FQ35826386-A102E7B5-8512-4EC0-992B-03E1EEC2FB89Q35875929-39492EF5-A219-4719-A927-DEADCE56C063Q35884208-91245D15-B356-40B8-B7F4-661CC561D111Q36047112-F8011BB1-CBD7-46A9-B709-1FB645BBB916Q36083619-1D98FC19-8BA6-4AF3-A5D3-839BE34E24D3Q36155441-CAA4508A-438A-4562-B1D4-D9ADC230A9AAQ36187937-7F481679-CC80-4FE4-BF0B-0328B652205EQ36313268-3D101A4D-A775-41B6-9787-08235E548734Q36437749-93DBC291-A977-46E8-B101-AFB5914F2ABDQ36505518-C243D6C9-E66A-46B1-AC56-622BDDE24783Q36527295-8AFDDF9B-1404-46EA-AD4B-57A1399158A8Q36670872-3177D690-F684-43AA-87E4-19FBA9A598D3Q36728061-FF20AF0C-4534-408B-AB51-95F29BAE94E6Q36817994-A1824DFB-5332-4E84-B415-49CF30B2A2D5Q36903693-52BB23C2-642C-4783-8316-DAC8ADCAE1E1Q36976649-34B4C453-96C9-41DE-847F-5EDCEE83E76EQ37188061-E0631119-66C3-4681-AB00-E7C127AE67F3Q37188136-A7400CFC-0C97-4308-8B6B-3277FC2FC42FQ37191156-FCDA5839-5D18-4DB4-8BF9-0F6145E21C42Q37274635-73225B40-9DFE-4A1C-9580-97A849D764D7Q37394523-C9B768CB-0E1D-4662-9181-6078D8D200A2Q37595559-5F02F756-DB48-45A2-BFC5-B5B039523784
P2860
Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Restricting the selection of a ...... from fluoroquinolone studies.
@ast
Restricting the selection of a ...... from fluoroquinolone studies.
@en
Restricting the selection of a ...... from fluoroquinolone studies.
@nl
type
label
Restricting the selection of a ...... from fluoroquinolone studies.
@ast
Restricting the selection of a ...... from fluoroquinolone studies.
@en
Restricting the selection of a ...... from fluoroquinolone studies.
@nl
prefLabel
Restricting the selection of a ...... from fluoroquinolone studies.
@ast
Restricting the selection of a ...... from fluoroquinolone studies.
@en
Restricting the selection of a ...... from fluoroquinolone studies.
@nl
P356
P1476
Restricting the selection of a ...... from fluoroquinolone studies.
@en
P304
P356
10.1086/321841
P407
P478
33 Suppl 3
P577
2001-09-01T00:00:00Z